Cardinal Health’s Accounting Is Probed
Cardinal Health Inc., the second-biggest U.S. drug wholesaler, said Wednesday that federal regulators subpoenaed documents in a probe of the company’s accounting.
Cardinal is conducting its own inquiry and is responding to the Securities and Exchange Commission inquiries, the statement said. Company spokesman Jim Mazzola declined to comment further.
The announcement was made after U.S. markets closed. Shares of Cardinal, which closed up 55 cents to $70.05, fell as low as $61.34 in after-hours trading.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
